Catalyst Wire Dossier Catalyst Wire Dossier

IBTROZI

taletrectinib · Nuvation Bio Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IBTROZI, covering 2025-06-11 to 2025-06-11. Get the full timeline:

Most recent: FDA Approved: IBTROZI — Original Application (Nuvation Bio Inc.)

See pricing